relapsed and refractory follicular lymphoma
Showing 1 - 1 of 1
Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma Trial in Guangzhou (Orelabrutinib and Rituximab, Orelabrutinib)
Recruiting
- Follicular Lymphoma
- Relapsed and Refractory Follicular Lymphoma
- Orelabrutinib and Rituximab
- Orelabrutinib
-
Guangzhou, Guangdong, China
- +2 more
Mar 23, 2022